Health Care: Drugs

Alseres Pharmaceuticals Inc. (ALSE: OTC)

$0.12 0.00 | 0.00%

05/31/12 - 01:42 PM ET

Company Cash Flow

Cash Flow From Operating Activities
	Dec 2011	Dec 2010	Dec 2009	Dec 2008
Net Income (Loss)	-2.88M	512.42K	-10.78M	-20.85M
Operating Gains/Losses	3.39K	-5.28M	0.00	0.00
Extraordinary Gains / Losses	0.00	0.00	0.00	0.00
(Increase) Decrease In Receivables	0.00	0.00	0.00	0.00
(Increase) Decrease in Inventories	0.00	0.00	0.00	0.00
(Increase) Decrease In Other Current Assets	0.00	0.00	0.00	0.00
(Decrease) Increase In Payables	-889.74K	116.97K	-1.44M	1.17M
(Decrease) Increase In Other Current Liabilities	1.83M	814.16K	1.76M	1.53M
(Increase) Decrease In Other Working Capital	-96.42K	0.00	0.00	0.00
Other Non-Cash Items	-506.14K	803.19K	2.19M	2.39M
Net Cash From Continuing Operations	-2.48M	-2.95M	-8.06M	-14.98M
Net Cash From Discontinued Operations	0.00	0.00	0.00	0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities	-2.48M	-2.95M	-8.06M	-14.98M
Sale of Property, Plant & Equipment	3.43K	0.00	0.00	0.00
Cash Used for Investing Activities
Sale of Short-Term Investments	0.00	0.00	0.00	1.23M
Purchases of Property, Plant & Equipment	-2.37K	0.00	0.00	-143.11K
Acquisitions	0.00	0.00	0.00	0.00
Purchases of Short-Term Investments	0.00	0.00	0.00	0.00
Other Cash from Investing Activities	300.33K	0.00	0.00	0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities	301.39K	35.02K	76.48K	1.12M
Issuance of Debt	2.24M	3.31M	1.35M	10.00M
Cash Used for Financing Activities
Issuance of Capital Stock	0.00	0.00	6.90M	1.00M
Repayment of Long-Term Debt	-1.00K	-602.70K	-25.19K	0.00
Repurchase of Capital Stock	-18.26K	-8.10K	0.00	0.00
Payment of Cash Dividends	0.00	0.00	0.00	0.00
Other Financing Charges, Net	0.00	0.00	0.00	0.00
Net Cash From Financing Activities	2.22M	2.70M	8.22M	11.00M
Effect of Exchange Rate Changes	0.00	0.00	0.00	0.00
Net Change in Cash & Cash Equivalents	37.33K	-216.45K	240.99K	-2.86M